Browse our anti-MET (MET) Antibodies

Full name:
anti-Met Proto-Oncogene Antibodies (MET)
On are 703 Met Proto-Oncogene (MET) Antibodies from 31 different suppliers available. Additionally we are shipping MET Kits (62) and MET Proteins (52) and many more products for this protein. A total of 843 MET products are currently listed.
AI838057, AUTS9, c-met, HGF, Hgfr, Par4, RCCP2
list all antibodies Gene Name GeneID UniProt
MET 4233 P08581
MET 17295  
MET 24553 P97523

Show all species

Show all synonyms

All available anti-MET Antibodies

Go to our pre-filtered search.

Top referenced anti-MET Antibodies

  1. Human Monoclonal MET Primary Antibody for FACS, IHC (p) - ABIN1688523 : Zagouri, Bago-Horvath, Rössler, Brandstetter, Bartsch, Papadimitriou, Dimitrakakis, Tsigginou, Papaspyrou, Giannos, Dimopoulos, Filipits: High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer. in British journal of cancer 2013 (PubMed)
    Show all 36 references for 1688523

  2. Human Polyclonal MET Primary Antibody for EIA, WB - ABIN358165 : Wong, Roskelley, Pelech, Miller, Leung, Auersperg: Progressive changes in Met-dependent signaling in a human ovarian surface epithelial model of malignant transformation. in Experimental cell research 2004 (PubMed)
    Show all 5 references for 358165

  3. Human Polyclonal MET Primary Antibody for EIA, IHC (p) - ABIN358164 : Mineo, Costantino, Frasca, Sciacca, Russo, Vigneri, Belfiore: Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels. in Endocrinology 2004 (PubMed)
    Show all 5 references for 358164

  4. Human Monoclonal MET Primary Antibody for FACS - ABIN4896926 : Tervonen, Belitškin, Pant, Englund, Marques, Ala-Hongisto, Nevalaita, Sihto, Heikkilä, Leidenius, Hewitson, Ramachandra, Moilanen, Joensuu, Kovanen, Poso, Klefström: Deregulated hepsin protease activity confers oncogenicity by concomitantly augmenting HGF/MET signalling and disrupting epithelial cohesion. in Oncogene 2016 (PubMed)
    Show all 3 references for 4896926

  5. Human Monoclonal MET Primary Antibody for FACS - ABIN4899935 : Vogel, Börger, Peters, Förster, Liebfried, Metzger, Meisel, Däubener, Trapp, Fischer, Gawaz, Sorg: Necrotic cell-derived high mobility group box 1 attracts antigen-presenting cells but inhibits hepatocyte growth factor-mediated tropism of mesenchymal stem cells for apoptotic cell death. in Cell death and differentiation 2015 (PubMed)
    Show all 3 references for 4899935

  6. Human Monoclonal MET Primary Antibody for FACS - ABIN4896921 : Baccelli, Schneeweiss, Riethdorf, Stenzinger, Schillert, Vogel, Klein, Saini, Bäuerle, Wallwiener, Holland-Letz, Höfner, Sprick, Scharpff, Marmé, Sinn, Pantel, Weichert, Trumpp: Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. in Nature biotechnology 2013 (PubMed)
    Show all 2 references for 4896921

  7. Human Polyclonal MET Primary Antibody for IF, ELISA - ABIN1533596 : Hillier, Fulton, Fulton, Graves, Pepin, Wagner-McPherson, Layman, Maas, Jaeger, Walker, Wylie, Sekhon, Becker, OLaughlin, Schaller, Fewell, Delehaunty, Miner, Nash, Cordes, Du, Sun, Edwards et al.: The DNA sequence of human chromosome 7. ... in Nature 2003 (PubMed)
    Show all 2 references for 1533596

  8. Human Polyclonal MET Primary Antibody for IHC (p), WB - ABIN389595 : Guo, Prins, Dang, Kuga, Iwanami, Soto, Lin, Huang, Akhavan, Hock, Zhu, Kofman, Bensinger, Yong, Vinters, Horvath, Watson, Kuhn, Robins, Mehta, Wen, DeAngelis, Prados, Mellinghoff, Cloughesy, Mischel: EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy. in Science signaling 2009 (PubMed)
    Show all 2 references for 389595

  9. Human Polyclonal MET Primary Antibody for DB - ABIN389596 : Xu, Xia, Baker, Zhou, Cha, Voorhees, Fisher: Receptor-type protein tyrosine phosphatase beta (RPTP-beta) directly dephosphorylates and regulates hepatocyte growth factor receptor (HGFR/Met) function. in The Journal of biological chemistry 2011 (PubMed)

  10. Human Monoclonal MET Primary Antibody for FACS - ABIN4896923 : Sie, den Dunnen, Lourens, Meeuwsen-de Boer, Scherpen, Zomerman, Kampen, Hoving, de Bont: Growth-factor-driven rescue to receptor tyrosine kinase (RTK) inhibitors through Akt and Erk phosphorylation in pediatric low grade astrocytoma and ependymoma. in PLoS ONE 2015 (PubMed)

More Antibodies against MET Interaction Partners

Human Met Proto-Oncogene (MET) interaction partners

  1. Furthermore, activation of HGF (show HGF Antibodies)/Met signaling increased the expression and transcriptional activity of FOXM1 (show FOXM1 Antibodies), and the cross talk between FOXM1 (show FOXM1 Antibodies) and HGF (show HGF Antibodies)/Met signaling promoted pancreatic ductal adenocarcinoma (PDA)growth and resistance to Met inhibition

  2. a c-Met/ETS-1 (show ETS1 Antibodies)/matrix metalloproteinase-14 (MMP-14 (show MMP14 Antibodies)) axis that controls VE-cadherin (show CDH5 Antibodies) degradation, endothelial mesenchymal transition, and vascular abnormality.

  3. c-Met overexpression is significantly associated with a poorer prognosis in esophageal cancer.. C-Met may serve as a potential novel prognostic biomarker for esophageal cancer patients (Meta-Analysis)

  4. Concurrent MET silver in situ hybridization positivity and KRAS mutation may predict a high risk of recurrence in pancreatobiliary subtype of ampullary adenocarcinomas

  5. Data suggest that combination regimens incorporating targeted inhibitors in patients with c-MET protein pathway activation could be of interest.

  6. MET inhibition by SGX523 and EGFR (show EGFR Antibodies)-MET heterodimerisation are determined by EGFR (show EGFR Antibodies) genotype.

  7. Report macrocyclic peptides targeting c-Met in gastric carcinoma.

  8. HPV-16 E6 was confirmed to regulate microRNA miR-23b indirectly through the DNA methylation of host gene C9orf3 and thus induce c-MET and inhibit apoptosis in cervical cancer cells.

  9. Studies provide evidence that MET amplification in non-small cell lung cancer is implicated in acquired resistance to EGFR (show EGFR Antibodies) inhibitors and has been reported in approximately one-fifth of cases with EGFR (show EGFR Antibodies) inhibitor resistance. [review]

  10. Using an integrative genetic analysis of 53 pediatric glioblastomas and five in vitro model systems, we identified previously unidentified gene fusions involving the MET oncogene (show RAB1A Antibodies) in approximately 10% of cases. These MET fusions activated mitogen-activated protein kinase (show MAPK1 Antibodies) (MAPK (show MAPK1 Antibodies)) signaling and, in cooperation with lesions compromising cell cycle regulation, induced aggressive glial tumors in vivo.

Mouse (Murine) Met Proto-Oncogene (MET) interaction partners

  1. a c-Met/ETS-1 (show ETS1 Antibodies)/matrix metalloproteinase-14 (MMP-14 (show MMP14 Antibodies)) axis that controls VE-cadherin (show CDH5 Antibodies) degradation, endothelial mesenchymal transition, and vascular abnormality.

  2. We found the roles of hepatocyte growth factor (HGF (show HGF Antibodies)) signaling in stria vascularis development for the first time and that lack of HGF (show HGF Antibodies) signaling in the inner ear leads to profound hearing loss in the mouse. Our findings reveal a novel mechanism that may underlie human deafness DFNB39 (show HGF Antibodies) and DFNB97. Our findings reveal an additional example of context-dependent c-MET signaling diversity, required here for proper cellular inva

  3. c-Met has been found to attenuate lung injury and apoptosis in bronchial epithelial cells.

  4. In this paper, we demonstrate a potential biochemical mechanism for such phenomena by showing that c-Met receptors promote the tyrosine phosphorylation of RalGDS (show RALGDS Antibodies) at Y752 in its RBD (show CACNA1D Antibodies), which blocks the binding of Ras to RalGDS (show RALGDS Antibodies).

  5. study demonstrates that co-activation of AKT (show AKT1 Antibodies) and c-Met induces hepatocellular carcinoma development that depends on the mTORC1/FASN (show FASN Antibodies) pathway.

  6. Molecular and functional studies revealed that ectopic Met expression in limb mesenchyme does not alter HGF (show HGF Antibodies) expression patterns and levels, but impairs HGF (show HGF Antibodies) bioavailability

  7. miR-206 suppressed c-Met expression in gastric cancer and could function as a potent tumor suppressor in c-Met overexpressing tumors.

  8. Meg3 overexpression in insulinoma cells down-regulated the expression of the protooncogene c-met.

  9. our results support the concept of the acrosome as a lysosome-related organelle and provide evidence for the identification of MET as a tyrosine kinase receptor (show KDR Antibodies) that may play a role in fertilization.

  10. We show that a subset of adult calcitonin gene-related peptide (CGRP (show CALCA Antibodies))-expressing myenteric neurons produce MET, the receptor for hepatocyte growth factor (show HGF Antibodies).

Cow (Bovine) Met Proto-Oncogene (MET) interaction partners

  1. possible cooperative role of the EGF (show EGF Antibodies) and HGF (show HGF Antibodies) pathways and indicate that cross-talk between their respective receptors may modulate mammary gland development in the cow

MET Antigen Profile

Antigen Summary

The proto-oncogene MET product is the hepatocyte growth factor receptor and encodes tyrosine-kinase activity. The primary single chain precursor protein is post-translationally cleaved to produce the alpha and beta subunits, which are disulfide linked to form the mature receptor. Various mutations in the MET gene are associated with papillary renal carcinoma. Two transcript variants encoding different isoforms have been found for this gene.

Alternative names and synonyms associated with MET

  • met proto-oncogene (MET) antibody
  • met proto-oncogene (Met) antibody
  • met proto-oncogene (hepatocyte growth factor receptor) (MET) antibody
  • AI838057 antibody
  • AUTS9 antibody
  • c-met antibody
  • HGF antibody
  • Hgfr antibody
  • Par4 antibody
  • RCCP2 antibody

Protein level used designations for MET

HGF receptor , HGF/SF receptor , SF receptor , hepatocyte growth factor receptor , met proto-oncogene tyrosine kinase , proto-oncogene c-Met , scatter factor receptor , tyrosine-protein kinase Met , c-Met , HGF receptor c-Met

4233 Homo sapiens
17295 Mus musculus
24553 Rattus norvegicus
403438 Canis lupus familiaris
280855 Bos taurus
654328 Sus scrofa
100126565 Oryctolagus cuniculus
Selected quality suppliers for anti-MET (MET) Antibodies
Did you look for something else?